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Introduction: The mutation of the
Insulin Receptor Substrate-1 gene is a
cause for insulin resistance. The
mutations is due to the replacement of
Gly with Arg at codon 972, which
leads to the formation of a defective
protein and that causes the
translocation of the GLUT-4 protein.
Purpose: To elucidate and describe
the biochemical mechanisms behind
insulin resistance (IR) that are at the
core of the creation of an effective
treatment for type 2 diabetes
Material and methods: This is the
synthesis of 20 medical research
articles published in the period of
2010-2020, found with the research
motors PubMed, Medscape, American
Physiological Society Journal.
Results: In obesity hypertrophied
adipocytes are the source of proinflamatory
cytokines, such TNFα, IL-6, resistin and
IFNγ, that increase overexpression of
suppressor of cytokine signaling
(SOCS1/SOCS3), which influences insulin
receptor-mediated phosphorylation of IRS1
and IRS2, there is a interruption of enzyme
cascade of reactions that are necessary for
the GLUT-4 translocation.
Conclusions: With the exception of the mutation in the Insulin Receptor Substrate-1 gene, all other pathogenic mechanisms 
of IR are essential for the development of effective medication in the treatment of patients with type 2 diabetes. 
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Interestingly, the core protein of hepatitis C virus upregulates SOCS3, which might
explain why infected patients have increased fasting insulin levels compared with
patients with other chronic liver diseases.
Nicotine binds to NAchR (nicotinic acetylcholine
α1 receptors, that increases mechanistic target
of rapamycin (mTOR)/p70S6K activity, which
leads to increased IRS-1 Ser 636
phosphorylation, and reduce insulin-stimulated
glucose uptake. Rapamycin is an mTOR
inhibitor, that blocks these effects of nicotine on
insuline resistance.
